Relationship between tumor and plasma levels of hTERT mRNA in patients with colorectal cancer: Implications for monitoring of neoplastic disease

Liliana Terrin, Enrica Rampazzo, Salvatore Pucciarelli, Marco Agostini, Roberta Bertorelle, Giovanni Esposito, Paola DelBianco, Donato Nitti, Anita De Rossi

Research output: Contribution to journalArticle

Abstract

Purpose: Colorectal cancer (CRC) is one of the most common cancers in western countries. Identification of circulating markers for CRC would optimize early stage diagnosis and the monitoring for disease recurrence. Expression of telomerase reverse transcriptase (hTERT) is essential to the oncogenic process and might be used as a molecular marker of neoplastic disease. Experimental Design: Eighty-five CRC samples (25 stage I, 15 stage II, 15 stage III, and 30 stage IV), the available corresponding noncancerous mucosa (n = 42), and plasma collected at the time of surgery (n = 49) were analyzed. Control plasma samples were obtained from 43 age-matched healthy subjects. All hTERT transcripts (hTERT-AT) and transcripts encoding the functional protein (hTERT-FL) were quantified by real-time PCR. Results: hTERT-AT was found to correlate with hTERT-FL (r = 0.849; P <0.0001) mRNA levels in tumors. Both hTERT mRNAs were significantly higher in tumors than in adjacent noncancerous mucosa and both significantly increased with tumor progression (P <0.0001). In contrast to controls, all but two plasma samples from CRC patients were positive for hTERT mRNAs. Using the cutoff value of 180 copies hTERT-AT/mL, the sensitivity and specificity of the assay for CRC detection were 92% and 100%, respectively. Furthermore, hTERT-AT mRNA levels in plasma significantly correlated with hTERT-AT mRNA levels in tumors (r = 0.702, P <0.0001). Conclusions: These findings indicate that quantification of hTERT mRNA in plasma may be used as a marker for detection and monitoring of neoplastic colorectal disease.

Original languageEnglish
Pages (from-to)7444-7451
Number of pages8
JournalClinical Cancer Research
Volume14
Issue number22
DOIs
Publication statusPublished - Nov 15 2008

Fingerprint

Colorectal Neoplasms
Messenger RNA
Neoplasms
Mucous Membrane
Telomerase
Real-Time Polymerase Chain Reaction
Early Diagnosis
Healthy Volunteers
Research Design
Recurrence
Sensitivity and Specificity
Proteins

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Relationship between tumor and plasma levels of hTERT mRNA in patients with colorectal cancer : Implications for monitoring of neoplastic disease. / Terrin, Liliana; Rampazzo, Enrica; Pucciarelli, Salvatore; Agostini, Marco; Bertorelle, Roberta; Esposito, Giovanni; DelBianco, Paola; Nitti, Donato; De Rossi, Anita.

In: Clinical Cancer Research, Vol. 14, No. 22, 15.11.2008, p. 7444-7451.

Research output: Contribution to journalArticle

Terrin, Liliana ; Rampazzo, Enrica ; Pucciarelli, Salvatore ; Agostini, Marco ; Bertorelle, Roberta ; Esposito, Giovanni ; DelBianco, Paola ; Nitti, Donato ; De Rossi, Anita. / Relationship between tumor and plasma levels of hTERT mRNA in patients with colorectal cancer : Implications for monitoring of neoplastic disease. In: Clinical Cancer Research. 2008 ; Vol. 14, No. 22. pp. 7444-7451.
@article{77b297c725d6429486fdfdc5e048a1b5,
title = "Relationship between tumor and plasma levels of hTERT mRNA in patients with colorectal cancer: Implications for monitoring of neoplastic disease",
abstract = "Purpose: Colorectal cancer (CRC) is one of the most common cancers in western countries. Identification of circulating markers for CRC would optimize early stage diagnosis and the monitoring for disease recurrence. Expression of telomerase reverse transcriptase (hTERT) is essential to the oncogenic process and might be used as a molecular marker of neoplastic disease. Experimental Design: Eighty-five CRC samples (25 stage I, 15 stage II, 15 stage III, and 30 stage IV), the available corresponding noncancerous mucosa (n = 42), and plasma collected at the time of surgery (n = 49) were analyzed. Control plasma samples were obtained from 43 age-matched healthy subjects. All hTERT transcripts (hTERT-AT) and transcripts encoding the functional protein (hTERT-FL) were quantified by real-time PCR. Results: hTERT-AT was found to correlate with hTERT-FL (r = 0.849; P <0.0001) mRNA levels in tumors. Both hTERT mRNAs were significantly higher in tumors than in adjacent noncancerous mucosa and both significantly increased with tumor progression (P <0.0001). In contrast to controls, all but two plasma samples from CRC patients were positive for hTERT mRNAs. Using the cutoff value of 180 copies hTERT-AT/mL, the sensitivity and specificity of the assay for CRC detection were 92{\%} and 100{\%}, respectively. Furthermore, hTERT-AT mRNA levels in plasma significantly correlated with hTERT-AT mRNA levels in tumors (r = 0.702, P <0.0001). Conclusions: These findings indicate that quantification of hTERT mRNA in plasma may be used as a marker for detection and monitoring of neoplastic colorectal disease.",
author = "Liliana Terrin and Enrica Rampazzo and Salvatore Pucciarelli and Marco Agostini and Roberta Bertorelle and Giovanni Esposito and Paola DelBianco and Donato Nitti and {De Rossi}, Anita",
year = "2008",
month = "11",
day = "15",
doi = "10.1158/1078-0432.CCR-08-0478",
language = "English",
volume = "14",
pages = "7444--7451",
journal = "Clinical Cancer Research",
issn = "1078-0432",
publisher = "American Association for Cancer Research Inc.",
number = "22",

}

TY - JOUR

T1 - Relationship between tumor and plasma levels of hTERT mRNA in patients with colorectal cancer

T2 - Implications for monitoring of neoplastic disease

AU - Terrin, Liliana

AU - Rampazzo, Enrica

AU - Pucciarelli, Salvatore

AU - Agostini, Marco

AU - Bertorelle, Roberta

AU - Esposito, Giovanni

AU - DelBianco, Paola

AU - Nitti, Donato

AU - De Rossi, Anita

PY - 2008/11/15

Y1 - 2008/11/15

N2 - Purpose: Colorectal cancer (CRC) is one of the most common cancers in western countries. Identification of circulating markers for CRC would optimize early stage diagnosis and the monitoring for disease recurrence. Expression of telomerase reverse transcriptase (hTERT) is essential to the oncogenic process and might be used as a molecular marker of neoplastic disease. Experimental Design: Eighty-five CRC samples (25 stage I, 15 stage II, 15 stage III, and 30 stage IV), the available corresponding noncancerous mucosa (n = 42), and plasma collected at the time of surgery (n = 49) were analyzed. Control plasma samples were obtained from 43 age-matched healthy subjects. All hTERT transcripts (hTERT-AT) and transcripts encoding the functional protein (hTERT-FL) were quantified by real-time PCR. Results: hTERT-AT was found to correlate with hTERT-FL (r = 0.849; P <0.0001) mRNA levels in tumors. Both hTERT mRNAs were significantly higher in tumors than in adjacent noncancerous mucosa and both significantly increased with tumor progression (P <0.0001). In contrast to controls, all but two plasma samples from CRC patients were positive for hTERT mRNAs. Using the cutoff value of 180 copies hTERT-AT/mL, the sensitivity and specificity of the assay for CRC detection were 92% and 100%, respectively. Furthermore, hTERT-AT mRNA levels in plasma significantly correlated with hTERT-AT mRNA levels in tumors (r = 0.702, P <0.0001). Conclusions: These findings indicate that quantification of hTERT mRNA in plasma may be used as a marker for detection and monitoring of neoplastic colorectal disease.

AB - Purpose: Colorectal cancer (CRC) is one of the most common cancers in western countries. Identification of circulating markers for CRC would optimize early stage diagnosis and the monitoring for disease recurrence. Expression of telomerase reverse transcriptase (hTERT) is essential to the oncogenic process and might be used as a molecular marker of neoplastic disease. Experimental Design: Eighty-five CRC samples (25 stage I, 15 stage II, 15 stage III, and 30 stage IV), the available corresponding noncancerous mucosa (n = 42), and plasma collected at the time of surgery (n = 49) were analyzed. Control plasma samples were obtained from 43 age-matched healthy subjects. All hTERT transcripts (hTERT-AT) and transcripts encoding the functional protein (hTERT-FL) were quantified by real-time PCR. Results: hTERT-AT was found to correlate with hTERT-FL (r = 0.849; P <0.0001) mRNA levels in tumors. Both hTERT mRNAs were significantly higher in tumors than in adjacent noncancerous mucosa and both significantly increased with tumor progression (P <0.0001). In contrast to controls, all but two plasma samples from CRC patients were positive for hTERT mRNAs. Using the cutoff value of 180 copies hTERT-AT/mL, the sensitivity and specificity of the assay for CRC detection were 92% and 100%, respectively. Furthermore, hTERT-AT mRNA levels in plasma significantly correlated with hTERT-AT mRNA levels in tumors (r = 0.702, P <0.0001). Conclusions: These findings indicate that quantification of hTERT mRNA in plasma may be used as a marker for detection and monitoring of neoplastic colorectal disease.

UR - http://www.scopus.com/inward/record.url?scp=58149352913&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=58149352913&partnerID=8YFLogxK

U2 - 10.1158/1078-0432.CCR-08-0478

DO - 10.1158/1078-0432.CCR-08-0478

M3 - Article

C2 - 19010861

AN - SCOPUS:58149352913

VL - 14

SP - 7444

EP - 7451

JO - Clinical Cancer Research

JF - Clinical Cancer Research

SN - 1078-0432

IS - 22

ER -